Novartis Investigative Site

Pierre-Benite Cédex F-69495

0 studies enrolling now · 4 studies all time

What they study most

Diffuse Large B-Cell Lymphoma, Graft-versus-host Disease (GVHD), Hodgkin's Lymphoma, Moderate to Severe Plaque-type Psoriasis, Non-Hodgkin's Lymphoma

Studies at this site

• A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3) — Completed
• Study of AEB071 (a Protein Kinase C Inhibitor) in Patients With CD79-mutant Diffuse Large B-Cell Lymphoma — Stopped early
• Study of HCD122 in Adults With Non-Hodgkin's or Hodgkin's Lymphoma Who Have Progressed After at Least Two Prior Therapies — Completed
• Efficacy and Safety of Subcutaneous Secukinumab (AIN457) for Moderate to Severe Chronic Plaque-type Psoriasis Assessing Different Doses and Dose Regimens — Completed